Cite
HARVARD Citation
Church, M. et al. (n.d.). A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic. Lung cancer. pp. S31-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Church, M. et al. (n.d.). A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic. Lung cancer. pp. S31-. [Online].